1. Home
  2. OGE vs GKOS Comparison

OGE vs GKOS Comparison

Compare OGE & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OGE Energy Corp

OGE

OGE Energy Corp

HOLD

Current Price

$44.79

Market Cap

9.4B

Sector

Utilities

ML Signal

HOLD

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$154.92

Market Cap

10.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OGE
GKOS
Founded
1902
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Electric Utilities: Central
Medical/Dental Instruments
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.4B
10.6B
IPO Year
2009
2015

Fundamental Metrics

Financial Performance
Metric
OGE
GKOS
Price
$44.79
$154.92
Analyst Decision
Buy
Strong Buy
Analyst Count
9
12
Target Price
$48.78
★ $126.92
AVG Volume (30 Days)
★ 1.4M
636.1K
Earning Date
04-29-2026
04-29-2026
Dividend Yield
★ 3.59%
N/A
EPS Growth
★ 5.94
N/A
EPS
★ 0.24
N/A
Revenue
★ $3,260,100,000.00
$507,442,000.00
Revenue This Year
$3.74
$23.32
Revenue Next Year
$1.42
$27.43
P/E Ratio
$184.50
★ N/A
Revenue Growth
9.21
★ 32.33
52 Week Low
$41.70
$73.16
52 Week High
$50.59
$191.62

Technical Indicators

Market Signals
Indicator
OGE
GKOS
Relative Strength Index (RSI) 38.82 33.05
Support Level $42.12 $145.78
Resistance Level $48.32 $161.53
Average True Range (ATR) 0.71 7.06
MACD -0.14 -2.33
Stochastic Oscillator 17.21 11.50

Price Performance

Historical Comparison
OGE
GKOS

About OGE OGE Energy Corp

OGE Energy is a holding company for Oklahoma Gas & Electric, a regulated utility with electricity generation, transmission, and distribution service for 900,000 customers in Oklahoma and western Arkansas. In December 2021, OGE divested its 25.5% stake in Enable Midstream Partners, an oil and gas services company it created in 2013 through a unit exchange merger with Energy Transfer. OGE sold its 95.4 million limited partner units of Energy Transfer throughout 2022. OGE sold its retail gas business in 1928 and no longer has any gas operations.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: